Qiagen N.V. (QGEN): R&D Expense
$187.52M
Year ended 2025-12-31
-0.4%
3-year compound annual growth
+4.7%
5-year compound annual growth
+2.5%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $187.52M | -3.1% | 2026-03-20, From 2025-01-01 |
| 2024-12-31 | $193.49M | -2.5% | 2026-03-20, From 2024-01-01 |
| 2023-12-31 | $198.51M | +4.6% | 2026-03-20, From 2023-01-01 |
| 2022-12-31 | $189.86M | -0.1% | 2025-03-31, From 2022-01-01 |
| 2021-12-31 | $189.96M | +27.4% | 2024-03-11, From 2021-01-01 |
| 2020-12-31 | $149.07M | -5.3% | 2023-03-13, From 2020-01-01 |
| 2019-12-31 | $157.45M | -2.7% | 2022-03-14, From 2019-01-01 |
| 2018-12-31 | $161.85M | +5.0% | 2021-03-05, From 2018-01-01 |
| 2017-12-31 | $154.08M | +2.8% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $149.84M | +2.1% | 2019-03-06, From 2016-01-01 |
| 2015-12-31 | $146.83M | -10.3% | 2018-03-06, From 2015-01-01 |
| 2014-12-31 | $163.67M | +12.0% | 2017-03-06, From 2014-01-01 |
| 2013-12-31 | $146.07M | +19.3% | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $122.48M | -6.2% | 2015-03-02, From 2012-01-01 |
| 2011-12-31 | $130.64M | +3.6% | 2014-03-03, From 2011-01-01 |
| 2010-12-31 | $126.04M | +16.8% | 2013-03-04, From 2010-01-01 |
| 2009-12-31 | $107.90M | +10.9% | 2012-03-27, From 2009-01-01 |
| 2008-12-31 | $97.33M | n/a | 2011-03-21, From 2008-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Qiagen N.V. (QGEN) | 2025-12-31 | $187.52M | -3.1% |
| Moderna, Inc. (MRNA) | 2025-12-31 | $3.13B | -31.1% |
| Exelixis, Inc. (EXEL) | 2026-01-02 | $825.00M | -9.4% |
| Neurocrine Biosciences Inc (NBIX) | 2025-12-31 | $1.02B | +38.9% |
| Halozyme Therapeutics, Inc. (HALO) | 2025-12-31 | $81.49M | +3.1% |
| Bio-Techne Corp (TECH) | 2026-06-30 | $94.77M | -4.8% |
| Novavax Inc (NVAX) | 2025-12-31 | $342.32M | -12.5% |
| BioCryst Pharmaceuticals Inc (BCRX) | 2025-12-31 | $166.13M | -4.9% |
| Repligen Corp (RGEN) | 2025-12-31 | $54.18M | +25.4% |
Compare QGEN, MRNA, EXEL, NBIX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗